Xyzal and Abraxane drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Xyzal (levocetirizine dihydrochloride) and Abraxane (paclitaxel). Common drug interactions include drug intolerance among females and febrile neutropenia among males.
The phase IV clinical study analyzes what interactions people have when they take Xyzal and Abraxane. It is created by eHealthMe based on reports of 9 people who take the same drugs from the FDA, and is updated regularly.
What is Xyzal?
Xyzal has active ingredients of levocetirizine dihydrochloride. It is often used in allergies. eHealthMe is studying from 21,479 Xyzal users. Check the latest studies of Xyzal.
What is Abraxane?
Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.
9 people who take Xyzal and Abraxane together, and have interactions are studied.
What are the common drug interactions of Xyzal and Abraxane, by gender? *:
female:
- Drug intolerance (drug sensitivity)
- Tumour haemorrhage (bleeding from tumour)
- Death
- Adverse event
male:
- Febrile neutropenia (fever with reduced white blood cells)
- Septic shock (shock due to blood infection)
- Abdominal pain
- Depressed level of consciousness
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Pulmonary radiation injury
- Radiation fibrosis - lung (fibrous tissue formation in lung due to radiation)
- Radiation mucositis (inflammation of oral mucosa resulting from chemotherapeutic agents or ionizing radiation)
What are the common drug interactions of Xyzal and Abraxane, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Febrile neutropenia (fever with reduced white blood cells)
- Septic shock (shock due to blood infection)
- Death
60+:
- Abdominal pain
- Adverse event
- Depressed level of consciousness
- Drug intolerance (drug sensitivity)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Pulmonary radiation injury
- Radiation fibrosis - lung (fibrous tissue formation in lung due to radiation)
- Radiation mucositis (inflammation of oral mucosa resulting from chemotherapeutic agents or ionizing radiation)
- Tumour haemorrhage (bleeding from tumour)
* Approximation only. Some reports may have incomplete information.
Do you take Xyzal and Abraxane?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Xyzal and Abraxane:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Xyzal:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Abraxane:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xyzal and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Abraxane and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on levocetirizine dihydrochloride and paclitaxel (the active ingredients of Xyzal and Abraxane, respectively), and Xyzal and Abraxane (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Exidine and Augmentin '125' - 15 seconds ago
- Drug interactions of Lamisil and Vitamins - 26 seconds ago
- Drug interactions of Cimzia and Accutane - 28 seconds ago
- Could L-Glutamine cause Gastrointestinal Disorder? - 29 seconds ago
- Osteopenia and Femur Fracture - 34 seconds ago
- Could Zemplar cause Speech Impairment (Adult)? - 36 seconds ago
- Drug interactions of Nintedanib and Hydrochlorothiazide - 39 seconds ago
- Could Trelegy Ellipta cause Pharyngitis? - 41 seconds ago
- Could Trelegy Ellipta cause Confusion? - 45 seconds ago
- Drug interactions of Arimidex and Cisplatin - 47 seconds ago